{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-025622","form_type":"8-K","ticker":null,"cik":"0001872812","company_name":"TC BioPharm (Holdings) plc","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.041143+00:00","generated_at":"2026-06-01T00:49:19.562139+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Two directors resign from TC Biopharm board effective June 26, 2024","bullets":["Mark Bonyhadi and Edward Niemzyck resigned from the board of directors on June 26, 2024, effective immediately.","Company states resignations were not due to any disagreement regarding operations, policies, or practices.","No replacement directors have been announced; board size reduced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-025622","json":"https://secwatch.observer/filing/0001493152-24-025622.json","markdown":"https://secwatch.observer/filing/0001493152-24-025622.md","text":"https://secwatch.observer/filing/0001493152-24-025622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872812/000149315224025622/0001493152-24-025622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872812/000149315224025622/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:49:19.562139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"354fd82991","claim":"Mark Bonyhadi resigned as Director at TC BioPharm (Holdings) plc.","evidence_excerpt":"On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872812/000149315224025622/0001493152-24-025622-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fd3ee4057c","claim":"Edward Niemzyck resigned as Director at TC BioPharm (Holdings) plc.","evidence_excerpt":"On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872812/000149315224025622/0001493152-24-025622-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}